Deputy Chief Medical Officer, Senior Physician
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Dr. Andrew J. Wagner is the Deputy Chief Medical Officer at Dana-Farber Cancer Institute and the Medical Director of Adult Ambulatory Oncology. As a medical oncologist and translational researcher in the Center for Sarcoma and Bone Oncology and Associate Professor of Medicine at Harvard Medical School, Dr. Wagner focuses on the treatment of patients with GIST and sarcoma, and conducts laboratory research and clinical studies to identify new targets and treatments for these diseases. He received a PhD in Biochemistry and Molecular and an MD from the University of Chicago Pritzker School of Medicine. Dr. Wagner completed his Internship and Residency in Internal Medicine at Brigham and Women’s Hospital in Boston, where he later served as Chief Medical Resident. He completed a fellowship in Hematology and Medical Oncology at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Massachusetts General Hospital, and then joined the Oncology Staff at Dana-Farber where he is currently a Senior Physician in the Department of Medical Oncology.
Friday, March 24, 2023
5:11 PM – 5:30 PM
Disclosure(s): Aadi Bioscience: Consultant (Ongoing), Research Grant (Ongoing); BioAlta: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Research Grant (Ongoing); Cogent Biosciences: Consultant (Ongoing), Research Grant (Ongoing); Daiichi-Sankyo: Consultant (Ongoing), Research Grant (Ongoing); Deciphera: Consultant (Ongoing), Research Grant (Ongoing); Eli Lilly: Consultant (Ongoing), Research Grant (Ongoing); Foghorn Therapeutics: Research Grant (Ongoing); InhibRx: Consultant (Ongoing); Karyopharm: Research Grant (Ongoing); Plexxikon: Research Grant (Ongoing); Rain Therapeutics: Research Grant (Ongoing); Servier Pharma: Consultant (Ongoing)